MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-24-2025
NovoCure Limited Operating Income 2011-2025 | NVCR
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income NovoCure Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -170 M | -233 M | -89.5 M | -44.3 M | 12.1 M | -914 K | -33.7 M | -39.3 M | -115 M | -104 M | -80.2 M | -64.5 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.1 M | -233 M | -80.2 M |
Quarterly Operating Income NovoCure Limited
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -39.5 M | -37.9 M | - | -32.1 M | -33.6 M | -41.5 M | - | -58.2 M | -62.7 M | -60.2 M | - | -24.6 M | -21.1 M | -806 K | -23.4 M | -8.55 M | -12.3 M | -88 K | 12.1 M | 30.4 M | 30.4 M | 30.4 M | 153 K | -914 K | -914 K | -914 K | -8.66 M | -33.7 M | -33.7 M | -33.7 M | -4.51 M | -39.3 M | -39.3 M | -39.3 M | -17.9 M | -115 M | -115 M | -115 M | -30.6 M | -104 M | -104 M | -104 M | - | -17.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 30.4 M | -115 M | -32.8 M |
Operating Income of other stocks in the Health care industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cigna Corporation
CI
|
9.42 B | $ 274.7 | - | $ 75.2 B |  USA |
 |
Anthem
ANTM
|
7.86 B | - | -2.32 % | $ 107 B | USA |
 |
Humana
HUM
|
2.56 B | $ 268.45 | 0.07 % | $ 32.4 B | USA |
 |
Molina Healthcare
MOH
|
1.71 B | $ 168.5 | - | $ 9.67 B | USA |
 |
Centene Corporation
CNC
|
3.18 B | $ 40.85 | - | $ 21.3 B | USA |
 |
CVS Health Corporation
CVS
|
8.52 B | $ 79.42 | - | $ 100 B | USA |
 |
UnitedHealth Group Inc.
UNH
|
32.3 B | $ 341.84 | - | $ 315 B | USA |